notice received, page-15

well...I am pretty new here so do not know people running the show as yet...so will take your word for it that the change over was a good move...reading the ann what "jumped" at me was that line
"Mr Malcolm McComas, Pharmaxis Chairman said: “Pharmaxis is facing likely delays in the commercialisation of Bronchitol in the United States"....

so maybe that was the reason for the slide in sp?..?... speculations that they may somehow convince the FDA to give a green light to 18+ instead of 6+ on the 18th seems very unlikely..other bits in the report were alluding to the delays in the entry to USA market as well...it is a large market so ppl maybe taking money out and putting it somewhere else for now. Personally I like being invested here...will accumulate..:-)...just my rumblings - hot AS in Adelaide so my thinking may be more confused then usual..lol